HIV molecular immunology database

 

Search the Epitope Variant and Escape Mutation Database

Results for CTL/CD8+ T-Cell Epitope Variants

Filter results by Mutation Type:

GELDRWEKIRLRPGGKKKYK Gag(11-30) B62 human epitope
GELDRWEKIRLRPGGKKKYK Gag(11-30) human epitope
GKLDAWEKIRLRPGGKKKYRL Gag(11-31) human epitope
-----WEKIRLRPGG------ Gag(11-31) non-susceptible form; susceptible form
GKLDAWEKIyLRPGGKKKYRL Gag(11-31) non-susceptible form; susceptible form
GKLDkWEKIRLRPGGKKKYRL Gag(11-31) non-susceptible form; susceptible form
---DrWEKIRLRPGGKKKYRL Gag(11-31) non-susceptible form; susceptible form
GKLDeWEKIRLRPGGKKKYRL Gag(11-31) non-susceptible form; susceptible form; subtype-specific susceptible form
GKLDeWEKIRLRPGGKKKYRL Gag(11-31) non-susceptible form; susceptible form; subtype-specific susceptible form
  LDRWEKIRLRPGGKK Gag(13-27) A3, B60 human epitope
  LDAWEKIRLRPGGKK Gag(13-27) human epitope
  LDRWEKIRLRPGGKK Gag(13-27) human epitope
   DRWEKIRLRPG Gag(14-24) B*40 human epitope
   DRWEKIRLRPG Gag(14-24) B*40 human epitope
   DAWEKIRLRPG Gag(14-24) human epitope
     WEKIRLRPGGKKKYK Gag(16-30) human epitope
      EKIRLRPGGKKYKL Gag(17-31) B27, B7 human epitope
      EKIRLRPGGKKKYRL Gag(17-31) human epitope
      EKIRLRPGGKKKYRL Gag(17-31) human epitope
      EKIRLRPGGKKKYRL Gag(17-31) human epitope
      EKIRLRPGGKKKYKL Gag(17-31) human epitope
      EKIRLRPGGKKKYqL Gag(17-31) non-susceptible form; susceptible form
      EKIRLRPGGKKKYRL Gag(17-31) human epitope
      EKIRLRPGGKKKYKL Gag(17-31) human epitope
      EKIRLRPGGKKKYRL Gag(17-31) human epitope
      EKIRLRPGGKKHYML Gag(17-31) human epitope
      EKIRLRPGGKKHYMLKHL Gag(17-34) C*17 human epitope
      EKIRLRPGGKKKYRLKHL Gag(17-34) human epitope
      EKIRLRPGGKKhYmLKHL Gag(17-34) subtype-specific susceptible form
      EKIRLRPGGKKKYKLKHI Gag(17-34) human epitope
      EKIRLRPGGKKKYKLKHI Gag(17-34) human epitope
      EKIRLRPGGKKKYKLKHI Gag(17-34) human epitope
      EKIRLRPGGKKHYMLKHL Gag(17-34) human epitope
      EKIRLRPGGKKKYKLKHI Gag(17-34) human epitope
       KIRLRPGGK Gag(18-26) A*03 human epitope
       KIRLRPGGn Gag(18-26) susceptible form
       KIRLRPeGK Gag(18-26) susceptible form
       KIkLRPGGK Gag(18-26) susceptible form
       KIqLRPGGK Gag(18-26) susceptible form
       KIkLRPGGr Gag(18-26) susceptible form
       KIRLRPGGK Gag(18-26) A*03 human epitope
       KIRLRPGGK Gag(18-26) A*03 human epitope
       KIRLRPGGK Gag(18-26) A*03 human epitope
       KIRLRPGGK Gag(18-26) A*03 human epitope
       KIRLRPGGK Gag(18-26) A*03 human epitope
       KIRLRPGGr Gag(18-26) literature escape; observed variant
       KIRLRPGGK Gag(18-26) A*03 human epitope
       KIRLRPGGK Gag(18-26) A*03 human epitope
       KIRLRPGGK Gag(18-26) A*03 human epitope
       KIRLRPGGK Gag(18-26) A*03:01 human epitope
       KIRLRPGGK Gag(18-26) A*03:01 human epitope
       KIRLRPGGK Gag(18-26) A*03:01 human epitope
       KIRLRPGGr Gag(18-26) diminished HLA binding or increased off-rate
       KIRLRPGGK Gag(18-26) A*03:01 human epitope
       rIRLRPGGK Gag(18-26) diminished response; escape documented in this paper; non-susceptible form
       KIRLRPGGK Gag(18-26) A*03:01 human epitope
       KIRLRPGGK Gag(18-26) A*03:01 human epitope
       KIRLRPGGK Gag(18-26) A*03:01 human epitope
       KIRLRPGGK Gag(18-26) A*03:01, A3, B27 human epitope
       KIRLRPGGK Gag(18-26) A11 human epitope
       KIRLRPGGK Gag(18-26) A3 human epitope
       KIRLRPGGK Gag(18-26) A3 human epitope
       KIRLRPGGK Gag(18-26) A3 human epitope
       KIRLRPGGK Gag(18-26) A3 human epitope
       KIRLRPGGK Gag(18-26) A3 human epitope
       KIRLRPGGr Gag(18-26) escape documented in this paper
       rIRLRPGGr Gag(18-26) escape documented in this paper
       KIRLRPGGK Gag(18-26) A3 human epitope
       KIRLRPGGK Gag(18-26) A3 human epitope
       KIRLRPGGK Gag(18-26) A3 human epitope
       KIRLRPGGK Gag(18-26) A3 human epitope
       KIRLRPGGK Gag(18-26) A3 human epitope
       KIRLRPGGK Gag(18-26) A3 human epitope
       KIRLRPGGK Gag(18-26) A3 human epitope
       KIRLRPGGK Gag(18-26) A3 human epitope
       KIRLRPGGK Gag(18-26) A3 human epitope
       KIRLRPGGK Gag(18-26) A3 human epitope
       KIRLRPGGK Gag(18-26) A3 human epitope
       KIRLRPGGK Gag(18-26) A3 human epitope
       KIRLRPGGr Gag(18-26) susceptible form
       KIRLRPGGK Gag(18-26) A3 human epitope
       KIRLRPGGK Gag(18-26) A3 human epitope
       KIRLRPGGK Gag(18-26) A3 human epitope
       KIRLRPGGr Gag(18-26) inferred escape
       KIRLRPGGK{Kr} Gag(18-26) observed variant
       KIRLRPGGK Gag(18-26) A3 human epitope
       KIRLRPGGK Gag(18-26) A3 human epitope
       KIRLRPGGK Gag(18-26) A3 human epitope
       KIRLRPGGq Gag(18-26) escape documented in this paper; processing
       KIRLRPGGK Gag(18-26) A3 epitope
       KIRLRPGGK Gag(18-26) A3 human epitope
       KIRLRPGGK Gag(18-26) A3 human epitope
       KIRLRPGGK Gag(18-26) A3 human epitope
       KIRLRPGGK Gag(18-26) A*30 human epitope
       KIRLRPGGK Gag(18-26) A*69 human epitope
       KIRLRPGGK Gag(18-26) B*27 human epitope
       KIRLRPGGK Gag(18-26) B7 human epitope
       KIRLRPGGK{*t} Gag(18-26) escape documented in this paper; processing
       KIRLRPGGK Gag(18-26) B*82 human epitope
       KIRLRPGGK Gag(18-26) human epitope
       KIRLRPGGK Gag(18-26) human epitope
       KIRLRPGGK Gag(18-26) human epitope
       KIRLRPGGK Gag(18-26) human epitope
       KIRLRPGGK Gag(18-26) human epitope
       KIRLRPGGKK Gag(18-27) A*03 human epitope
       KIRLRPGGKK Gag(18-27) A*03, A*11, B*07, B*27 human epitope
       KIRLRPGGKK Gag(18-27) A*03:01 human epitope
       KIRLRPGGKK Gag(18-27) A11 human epitope
       KIRLRPGGKK Gag(18-27) A11 human epitope
       KIRLRPGGKK Gag(18-27) B*27 human epitope
       KIRLRPGGKK Gag(18-27) B*27 human epitope
       KIRLRPGGKK Gag(18-27) B27 human epitope
       KIRLRPGGKK Gag(18-27) B27 human epitope
       KIRLRPGGKK Gag(18-27) B27 human epitope
       KIRLRPGGKK Gag(18-27) B27 human epitope
       KIRLRPGGKK Gag(18-27) B27, B35 human epitope
       KIRLRPGGKK Gag(18-27) B*27:05 human epitope
       KIRLRPGGKKKYKL Gag(18-31) A3 human epitope
       KIRLRPGGKKKYKL Gag(18-31) B62 human epitope
       KIRLRPGGKKKYKLK Gag(18-32) B*57 human epitope
       KIRLRPGGKKKYKLK Gag(18-32) macaque epitope
       KIRLRPGGKKKYKLKHIVWASRELE Gag(18-42) A3 human epitope
       KIRLRPGGKKKYKLKHIVWASRELE Gag(18-42) A3 human epitope
       KIRLRPGGKKKYKLKHIVWASRELE Gag(18-42) B62 human epitope
        IRLRPGGKK Gag(19-27) A*03 human epitope
        IRLRPGGKK Gag(19-27) A*30 human epitope
        IRLRPGGKK Gag(19-27) A*68:02 human epitope
        IRLRPGGKK Gag(19-27) B*27 human epitope
        IRLRPGGKK Gag(19-27) B*27 human epitope
        IRLRPGGKK Gag(19-27) B*27 human epitope
        IRLRPGGKK Gag(19-27) B27 human epitope
        IRLRPGGKK Gag(19-27) B27 human epitope
        IRLRPGGrK Gag(19-27) susceptible form
        IRLRPGGKK Gag(19-27) B27 human epitope
        IRLRPGGKK Gag(19-27) B27 human epitope
        IRLRPGGKK Gag(19-27) B27 human epitope
        IRLRPGrKK Gag(19-27) observed variant
        IRLRPrrKK Gag(19-27) observed variant
        IRkRPGGKK Gag(19-27) observed variant
        IRLgPGGsK Gag(19-27) inferred escape
        IRLRPGGsK Gag(19-27) inferred escape
        IRLRPGGKK Gag(19-27) B27 human epitope
        IRLRPGGKK Gag(19-27) B27 scid-hu mouse epitope
        IRLRPGGKK Gag(19-27) B27 human epitope
        IRLRPGGKK Gag(19-27) B*27:02 human epitope
        IRLRPGGKK Gag(19-27) B*27:05 human epitope
        IRLRPGGKK Gag(19-27) B*27:05 human epitope
        IRLRPGGKK Gag(19-27) B*27:05 human epitope
        IRLRPGGKK Gag(19-27) B*27:05 human epitope
        IRLRPGGKK Gag(19-27) B*27:05 human epitope
        IRLRPGGKK Gag(19-27) B*81 human epitope
        IRLRPGGKK Gag(19-27) B*82 human epitope
        IRLRPGGKK Gag(19-27) C*12 human epitope
        IRLRPGGKK Gag(19-27) human epitope
        IRLRPGGKK Gag(19-27) human epitope
        IRLRPGGKK Gag(19-27) human epitope
        IRLRPGGKK Gag(19-27) human epitope
        IRLRPGGKK Gag(19-27) human epitope
        IRLRPGGKKK Gag(19-28) A11, A3, B62 human epitope
        IRLRPGGKKK Gag(19-28) human epitope
        IRLRPGGKKK Gag(19-28) human epitope
         RLRPGGKKK Gag(20-28) A*02:01 human epitope
         RLRPGGKKK Gag(20-28) A*03 human epitope
         RLRPGGKKK Gag(20-28) A*03 human epitope
         RLRPGGKKK Gag(20-28) A*03 human epitope
         RLRPGGKKK Gag(20-28) A*03 human epitope
         RLRPGGKKc Gag(20-28) escape documented in this paper
         RLRPGGKKK Gag(20-28) A*03 human epitope
         RLRPGGKKK Gag(20-28) A*03 human epitope
         RLRPGGKKK Gag(20-28) A*03 human epitope
         RLRPGGKKK Gag(20-28) A*03 human epitope
         RLRPGGKKK Gag(20-28) A*03 human epitope
         RLRPGGKKK Gag(20-28) A*03 human epitope
         RLRPGGKKK Gag(20-28) A*03 human epitope
         RLRPGGKKK Gag(20-28) A*03 human epitope
         RLRPGGKKK Gag(20-28) A*03 human epitope
         RLRPGGKKK Gag(20-28) A*03 human epitope
         RLRPGGKKK Gag(20-28) A*03 human epitope
         RLRPGGKKK Gag(20-28) A*03 human epitope
         RLRPGGKKK Gag(20-28) A*03 human epitope
         RLRPGGKKK Gag(20-28) A*03 human epitope
         RLRPGGKKQ Gag(20-28) A*03:01 human epitope
         RLRPGGKKk Gag(20-28) non-susceptible form
         RLRPGGKKr Gag(20-28) diminished response; escape documented in this paper; non-susceptible form
         RLRPGGKKK Gag(20-28) A*03:01 human epitope
         RLRPGGKKq Gag(20-28) escape documented in this paper
         RLRPGGKKK Gag(20-28) A*03:01 human epitope
         RLRPGGrKK Gag(20-28) observed variant
         RLRPGGrKt Gag(20-28) escape documented in this paper
         RLRPGGKKq Gag(20-28) diminished HLA binding or increased off-rate; escape documented in this paper
         RLRPGGKKK Gag(20-28) A*03:01 human epitope
         RLRPGGKKK Gag(20-28) A*03:01 human epitope
         RLRPGGKKq Gag(20-28) diminished response; escape documented in this paper; non-susceptible form
         RLRPGGKKr Gag(20-28) diminished response; escape documented in this paper; non-susceptible form
         RLRPGGKKK Gag(20-28) A*03:01 human epitope
         RLRPGGKKK Gag(20-28) A*03:01 human epitope
         RLRPGGKKK Gag(20-28) A*03:01 human epitope
         RLRPGGKKK Gag(20-28) A*03:01 human epitope
         RLRPGGKKK Gag(20-28) A*03:01 human epitope
         RLRPGGKKK Gag(20-28) A*03:01 human epitope
         RLRPGGKKK Gag(20-28) A*03:01 human epitope
         RLRPGGKKK Gag(20-28) A*03:01 human epitope
         {rWEKI}RLRPGGKKK Gag(20-28) inferred escape
         RLRPGGKKK Gag(20-28) A*03:01 human epitope
         RLRPGGKKK Gag(20-28) A*03:01 human epitope
         RLRPGGKKK Gag(20-28) A*03:01 human epitope
         RLRPGGKKK Gag(20-28) A*03:01, A3, B42, B62 human epitope
         RLRPGGKKK Gag(20-28) A11 human epitope
         RLRPGGKKK Gag(20-28) A3 human epitope
         RLRPGGKKK Gag(20-28) A3 human epitope
         RLRPGGKKK Gag(20-28) A3 human epitope
         RLRPGGKKh Gag(20-28) subtype-specific susceptible form
         RLRPGGKKK Gag(20-28) A3 human epitope
         RLRPGGKKt Gag(20-28) diminished response
         RLRPGGKKK Gag(20-28) A3 human epitope
         RLRPGGKKK Gag(20-28) A3 human epitope
         RLRPGGKKh Gag(20-28) diminished response
         RLRPGGKKK Gag(20-28) A3 human epitope
         RLRPGGKKK Gag(20-28) A3 human epitope
         RLRPGGKKK Gag(20-28) A3 human epitope
         RLRPGGKKK Gag(20-28) A3 human epitope
         RLRPGGKKK Gag(20-28) A3 human epitope
         RLRPGGKKK Gag(20-28) A3 human epitope
         RLRPGGKKK Gag(20-28) A3 human epitope
         RLRPGGKKK Gag(20-28) A3 human epitope
         RLRPGGKKr Gag(20-28) susceptible form
         RLRPGGKKK Gag(20-28) A3 human epitope
         RLRPGGKKK Gag(20-28) A3 epitope
         RLRPGGKKK Gag(20-28) A3 human epitope
         RLRPGGKKK Gag(20-28) A3 human epitope
         RLRPGGKqK Gag(20-28) escape documented in this paper
         RLRPGGKKK Gag(20-28) A3 human epitope
         RPRPGGKKK Gag(20-28) A3 human epitope
         RLRPGGKKK Gag(20-28) A3 human epitope
         RLRQGGKKK Gag(20-28) A3 human epitope
         RLRPGGKKK Gag(20-28) A3 human epitope
         RLRPGGKKK Gag(20-28) A3 human epitope
         RLRPGGKKK Gag(20-28) A3 human epitope
         RLRPGGKKK Gag(20-28) A3 human epitope
         RLRPGGKKK Gag(20-28) A3 human epitope
         RLRPGGKKK Gag(20-28) A3, A30, A31, A68 epitope
         RLRPGGKKK Gag(20-28) A3, A30, B42, B62 human epitope
         RLRPGGKKq Gag(20-28) diminished response; susceptible form
         RLRPGGKKr Gag(20-28) susceptible form
         RLRPGGKKK Gag(20-28) A3, B7 human epitope
         RLRPGGrKr Gag(20-28) susceptible form
         RLRPGGKKr Gag(20-28) susceptible form
         RLRPGGKKK Gag(20-28) A*30 human epitope
         RLRPGGKKK Gag(20-28) A*74 human epitope
         RLRPGGKKK Gag(20-28) B*07:02 human epitope
         RLRPGGKKK Gag(20-28) C*01 human epitope
         RLRPGGKKK Gag(20-28) human epitope
         RLRPGGKKK Gag(20-28) human epitope
         RLRPGGKKK Gag(20-28) human epitope
         RLRPGGKKK Gag(20-28) human epitope
         RLRPGGKKK Gag(20-28) human epitope
         RLRPGGKKK Gag(20-28) human epitope
         RLRPGGKKKY Gag(20-29) A*03 human epitope
         RLRPGGKKKY Gag(20-29) A*03 human epitope
         RLFPGGKKKY Gag(20-29) A*03 human epitope
         RLRPGGKKKY Gag(20-29) A*03 human epitope
         RLRPGGKKKY Gag(20-29) A*03 human epitope
         RLRPGGKKKY Gag(20-29) A*03:01 human epitope
         RLRPGGKKKY Gag(20-29) A*03:01 human epitope
         RLRPGGKKKY Gag(20-29) A*03:01 human epitope
         RLRPGGKKKY Gag(20-29) A*03:01 human epitope
         RLRPGGKKKY Gag(20-29) A*03:01 human epitope
         RLRPGGKKKY Gag(20-29) A*03:01 human epitope
         RLRPGGKKKY Gag(20-29) A*03:01 human epitope
         RLRPGGKKKY Gag(20-29) A*03:01 human epitope
         RLRPGGKKqY Gag(20-29) HLA association
         RLRPGGKKKY Gag(20-29) A*03:01, A30 human epitope
         RLRPGGKKKY Gag(20-29) A3 human epitope
         RLRPGGKKhY Gag(20-29) susceptible form; subtype-specific susceptible form
         RLRPGGKKrY Gag(20-29) susceptible form; subtype-specific susceptible form
         RLRPGGKKqY Gag(20-29) susceptible form; subtype-specific susceptible form
         qLRPGGKKrY Gag(20-29) susceptible form; subtype-specific susceptible form
         RLRPGGKKKY Gag(20-29) A3 human epitope
         RLRPGGKKKK Gag(20-29) A3 human epitope
         RLRPGGKKKKY Gag(20-29) A3 human epitope
         RLRPGGKKKY Gag(20-29) A3 human epitope
         RLRPGGKKKK Gag(20-29) A3 human epitope
         RLRPGGKKKY Gag(20-29) A3, A30, B42, B62 human epitope
         RLRPGGKKKY Gag(20-29) A*30 human epitope
         RLRPGGKKqY Gag(20-29) diminished response
         RLRPGGKKrY Gag(20-29) diminished response
         RLRPGGKKKY Gag(20-29) A*30 human epitope
         RLRPGGKKKY Gag(20-29) A*30:01 human epitope
         RLRPGGKKqY Gag(20-29) HLA association
         RLRPGGKKHY Gag(20-29) A*30:02 human epitope
         RLRPGGKKKY Gag(20-29) B*15 human epitope
         RLRPGGKKKY Gag(20-29) B*15 human epitope
         RLRPGGKKKY Gag(20-29) B*15 human epitope
         RLRPGGKKKY Gag(20-29) B*15:01 human epitope
         RLRPGGKKKY Gag(20-29) B*15:40 human epitope
         RLRPGGKKKY Gag(20-29) B42 human epitope
         RLRPGGKKKY Gag(20-29) B42, B62 human epitope
         RLRPGGKKHY Gag(20-29) B*42:01 human epitope
         kLRPGGKKHY Gag(20-29) inferred escape
         kLRPGGKKrY Gag(20-29) inferred escape
         RLRPGGKKrY Gag(20-29) inferred escape
         RLRPGGKKqY Gag(20-29) inferred escape
         RLRPGGKKHY Gag(20-29) B*42:01 human epitope
         RLRPGGKKKY Gag(20-29) B*44 human epitope
         RLRPGGKKKY Gag(20-29) B62 human epitope
         RLRPGGKKKY Gag(20-29) B62 human epitope
         RLRPGGrKKY Gag(20-29) susceptible form
         RLRPGGKKKY Gag(20-29) B62 human epitope
         RLRPGGKKKY Gag(20-29) C*02 human epitope
         RLRPGGKKKY Gag(20-29) C*06 human epitope
         RLRPGGKKKY Gag(20-29) C*14 human epitope
         RLRPGGKKKY Gag(20-29) C*16 human epitope
         RLRPGGKKKY Gag(20-29) human epitope
         RLRPGGKKKY Gag(20-29) human epitope
         RLRPGGKKKY Gag(20-29) human epitope
         RLRPGGKKKY Gag(20-29) human epitope
         RLRPGGKKHYM Gag(20-30) human epitope
         RLRPGGKKKYK Gag(20-30) human epitope
         RLRPGGKKRYRL Gag(20-31) human epitope
         RLRPGGKKkYRL Gag(20-31) subtype-specific susceptible form
         CLRPGGKKKYKLKHIV Gag(20-35) human epitope
          LRPGGKKKY Gag(21-29) C*06:02 human epitope
          LRPGGKKKY Gag(21-29) human epitope
          LRPGGKKKYKLKHIV Gag(21-35) A11, B7 human epitope
          LRPGGKKKYKLKHIV Gag(21-35) A3 human epitope
          LRPGGKKKYKLKHIV Gag(21-35) A3 human epitope
          LRPGGKKKYKLKHIV Gag(21-35) B*08 human epitope
          LRPGGKKqYKLKHIV Gag(21-35) susceptible form
          LRPGGKKKYKLKHIV Gag(21-35) B8 human epitope
          LRPGGKKKYKLKHIV Gag(21-35) B8 human epitope
          LRPGGKKKYRLKHLV Gag(21-35) human epitope
          LRPGGKKKYkLKHLV Gag(21-35) observed variant
          LRPGGKKKYKLKHIV Gag(21-35) human epitope
          LRPGGKKKYKLKHIV Gag(21-35) human epitope
          LRPGGKKKYKLKHIV Gag(21-35) human epitope
          LRPGGKKKYKLKHIV Gag(21-35) human epitope
          LRPGGKKrYKLKHIV Gag(21-35) susceptible form
          LRPGGKKKYrLKHlV Gag(21-35) susceptible form
          LRPGGKKKYrLKHIV Gag(21-35) susceptible form
          LRPGGKKKYRLKHLVWASRE Gag(21-40) Cw4 human epitope
          LRPGGKKKYkLKHiVWASRE Gag(21-40) subtype-specific non-susceptible form
          LRPGGKKKYRLKHLVWASRE Gag(21-40) human epitope
          LRPGGKKKYKLKHIVWASRE Gag(21-40) human epitope
           RPGGKKHY Gag(22-29) B42, B7 human epitope
           RPGGKKkY Gag(22-29) diminished response
           RPGGKKqY Gag(22-29) diminished response
           RPGGKKHYM Gag(22-30) B*07:02 human epitope
           RPGGKKHYM Gag(22-30) B*07:02 human epitope
           RPGGKKkYk Gag(22-30) subtype-specific non-susceptible form
           RPGGKKHYM Gag(22-30) B*07:02, B*42:01 human epitope
           RPGGKKqYM Gag(22-30) escape documented in this paper; replicative capacity reduced
           RPGGKKsYM Gag(22-30) escape documented in this paper; replicative capacity reduced
           RPGGKKHYr Gag(22-30) escape documented in this paper; replicative capacity reduced
           RPGGKKHYk Gag(22-30) escape documented in this paper; replicative capacity reduced
           RPGGKKHYM Gag(22-30) B*42:01 human epitope
           {IsL}RPGGKKHYM Gag(22-30) escape documented in this paper; observed variant
           RPGGKKqYM Gag(22-30) diminished response; escape documented in this paper; observed variant
           RPGGKKsYM Gag(22-30) diminished response; escape documented in this paper; observed variant
           RPGGKKrYM Gag(22-30) diminished response; escape documented in this paper; observed variant
           RPGGKKHYk Gag(22-30) diminished response; escape documented in this paper; observed variant
           RPGGKKHYM Gag(22-30) B*42:01 human epitope
           RPGGKKHYM Gag(22-30) B*42:01, B*42:02 human epitope
           RPGGKKrYM Gag(22-30) escape documented in this paper
           RPGGKKHYk Gag(22-30) observed variant
           RPGGKKHYr Gag(22-30) observed variant
           RPGGKKKKYK Gag(22-30) B7 human epitope
           RPGGrKKrYK Gag(22-30) susceptible form
           RPGGKKKrYK Gag(22-30) susceptible form
           RPGGKKKKYr Gag(22-30) susceptible form
           RPGGKKRYM Gag(22-30) human epitope
           RPGGKKKYML Gag(22-31) B*07:02, B*42:01 human epitope
           RPGGKKKYKL Gag(22-31) B*51:01 human epitope
           RPGGKKKYKL Gag(22-31) B*51:01 human epitope
           RPGGKKRYKL Gag(22-31) B7 human epitope
           RPGGKKKYKL Gag(22-31) Cw4 human epitope
           RPGGnKKYKL Gag(22-31) observed variant
           RPGGKKKYKL Gag(22-31) human epitope
            PGGKKRYRLKHL Gag(23-34) human epitope
            PGGKKkYRLKHL Gag(23-34) subtype-specific susceptible form
             GGKKKYKL Gag(24-31) B*08 human epitope
             GGKKKYKL Gag(24-31) B*08 human epitope
             GGKKKYKL Gag(24-31) B*08 human epitope
             GGKKKYKL Gag(24-31) B*08 human epitope
             GGrKKYKL Gag(24-31) reversion
             GGKKKYRL Gag(24-31) B*08:01 human epitope
             GGKKKYKL Gag(24-31) B*08:01 human epitope
             GGKKKYKL Gag(24-31) B*08:01 human epitope
             GGrKKYKL Gag(24-31) escape documented in this paper
             GGKKqYrL Gag(24-31) diminished HLA binding or increased off-rate; escape documented in this paper
             GGKKKYKL Gag(24-31) B8 human epitope
             GGKKKYKL Gag(24-31) B8 human epitope
             GGKKKYKL Gag(24-31) B8 human epitope
             GGKKKYRL Gag(24-31) B8 human epitope
             GGKKKYKL Gag(24-31) B8 human epitope
             GGKKKYKL Gag(24-31) B8 human epitope
             GGKKKYrL Gag(24-31) subtype-specific non-susceptible form
             GGnKrYrL Gag(24-31) subtype-specific non-susceptible form
             GGKKKYqL Gag(24-31) subtype-specific non-susceptible form
             GGKKKYrm Gag(24-31) subtype-specific non-susceptible form
             GGsKKYKL Gag(24-31) subtype-specific non-susceptible form
             GGKKtYqL Gag(24-31) subtype-specific non-susceptible form
             GGKKKYKL Gag(24-31) B8 human epitope
             GGKKKYKL Gag(24-31) B8 human epitope
             GGKKKYKf Gag(24-31) escape documented in this paper
             GGKKKYKL Gag(24-31) B8 human epitope
             GGKKKYKL Gag(24-31) B8 human epitope
             GGKKKYKL Gag(24-31) B8 human epitope
             GGKKKYKm Gag(24-31) observed variant
             GGKKKYKL Gag(24-31) B8 human epitope
             GGKKqYKL Gag(24-31) escape documented in this paper
             erKKqYKL Gag(24-31) observed variant
             GGKKKYKL Gag(24-31) C*01 human epitope
             GGKKKYKL Gag(24-31) human epitope
             GGKKKYKL Gag(24-31) human epitope
             GGKKKYKLK Gag(24-32) A*30 human epitope
             GGKKKYKLK Gag(24-32) B*08 human epitope
             GGKKKYKLK Gag(24-32) B*08 human epitope
             GGKKKYKLK Gag(24-32) B*08:01 human epitope
             GGKKKYKLK Gag(24-32) B*08:01 human epitope
             GGKKKYKLK Gag(24-32) B*08:01 human epitope
             GGKKKYKMK Gag(24-32) B*35 human epitope
             GGKKKYKLK Gag(24-32) B8 human epitope
             GGKKKYKLK Gag(24-32) B8 human epitope
             GGrKKYKLK Gag(24-32) escape documented in this paper; susceptible form
             GGKKKYKLK Gag(24-32) B8 human epitope
             GGKKKYKLK Gag(24-32) B8 human epitope
             GGKKKYKLK Gag(24-32) B8 human epitope
             GGKKKYKLK Gag(24-32) B8 human epitope
             GGKKKYKLK Gag(24-32) B8 human epitope
             GGKKKYKLK Gag(24-32) B8 human epitope
             GGKKKYKLK Gag(24-32) B8 epitope
             GGKKKYKLK Gag(24-32) B8 human epitope
             GGKKKYKLK Gag(24-32) B8 human epitope
             GGKKKYKLK Gag(24-32) B8 human epitope
             GGKKKYQLK Gag(24-32) human epitope
             GGKKKYKLK Gag(24-32) human epitope
             GGKKKYKLKHIV Gag(24-35) B8 human epitope
             GGKKKYKLKHIi Gag(24-35) susceptible form
             GrKKKYKLKHIV Gag(24-35) escape documented in this paper
             GrKKKYKfKHIV Gag(24-35) escape documented in this paper
             rGKKrYKLKHIV Gag(24-35) observed variant
             GGKKqYrLKHIV Gag(24-35) observed variant
             GGKKKYqLKHIV Gag(24-35) observed variant
             GGKKKYaLKHli Gag(24-35) observed variant
             GGKKKYKLKHIV Gag(24-35) B8 human epitope
             GGKKKYKLKHIVWASR Gag(24-39) human epitope
              GKKPYMLKHL Gag(25-34) human epitope
              GKKsYMLKHL Gag(25-34) diminished response; escape documented in this paper
              GKKPYrLKHL Gag(25-34) diminished response; escape documented in this paper
              GKKKYKLKHIVWASR Gag(25-39) A24, B7 human epitope
              GKKKYKLKHIVWASR Gag(25-39) human epitope
              GKKHYMLKHLVWASR Gag(25-39) human epitope
              GKKHYMLKHLVWASREL Gag(25-41) C*03 human epitope
              GKKQYKLKHIVWASRELE Gag(25-42) human epitope
               KKHYMLKHIVWASRE Gag(26-40) human epitope
               KKHYMLKHlVWASRE Gag(26-40) subtype-specific susceptible form
               {g}KKkYkLKHlVWASR Gag(26-40) subtype-specific non-susceptible form
               KKkYrLKHlVWASRE Gag(26-40) subtype-specific non-susceptible form
               KKkYrLKHlVWASRE Gag(26-40) subtype-specific non-susceptible form
                KRYMIKHLV Gag(27-35) human epitope
                 KYKLKHIVW Gag(28-36) A*23 human epitope
                 KYKLKHIVW Gag(28-36) A*23 human epitope
                 qYKLKHIVW Gag(28-36) susceptible form
                 KYKLKHIVW Gag(28-36) A23 human epitope
                 HYMLKHIVW Gag(28-36) A*23:01 human epitope
                 HYMLKHLVW Gag(28-36) A*23:01 human epitope
                 HYMLKHLVW Gag(28-36) A*23:01 human epitope
                 HYMLKHIVW Gag(28-36) A*23:01 human epitope
                 kYrLKHlVW Gag(28-36) diminished response
                 qYrmKHlVW Gag(28-36) diminished response
                 HYMLKHLVW Gag(28-36) A*23:01, A*24:02 human epitope
                 HYMLKHLVW Gag(28-36) A*23:01, A*24:02 human epitope
                 KYRLKHIVW Gag(28-36) A*24 human epitope
                 qYRLKHvVW Gag(28-36) observed variant
                 qYRLKHIVW Gag(28-36) observed variant
                 KYRLKHvVW Gag(28-36) observed variant
                 KYKLKHIVW Gag(28-36) A*24 human epitope
                 KYKLKHIVW Gag(28-36) A*24 human epitope
                 KYKLKHIVW Gag(28-36) A*24 human epitope
                 KYKmKHlVW Gag(28-36) subtype-specific non-susceptible form
                 KYKLKHIVW Gag(28-36) A*24 human epitope
                 qYKLKHIVW Gag(28-36) escape documented in this paper; literature escape
                 KYMLKHIVW Gag(28-36) A*24 human epitope
                 KYKLKHIVW Gag(28-36) A*24 human epitope
                 KYKLKHIVW Gag(28-36) A24 human epitope
                 KYrLKHlVW Gag(28-36) escape documented in this paper; processing; susceptible form
                 qYKLKHIVW Gag(28-36) escape documented in this paper; processing; susceptible form
                 rYrLKHlVW Gag(28-36) escape documented in this paper; processing; susceptible form
                 KYKLKHIVW Gag(28-36) A24 human epitope
                 KYKLKHIVW Gag(28-36) A24 human epitope
                 KYKLKHIVW Gag(28-36) A24 human epitope
                 KYKLKHIVW Gag(28-36) A24 human epitope
                 KYKLKHIVW Gag(28-36) A24 human epitope
                 KYKLKHIVW Gag(28-36) A24 human epitope
                 KYRLKHIVW Gag(28-36) A*24:02 human epitope
                 KYKLKHIVW Gag(28-36) A*24:02 human epitope
                 KYrLKHIVW Gag(28-36) epitope loss; literature escape
                 KYKLKHIVW Gag(28-36) A*24:02 human epitope
                 KYKLKHIVW Gag(28-36) A*24:02 human epitope
                 KYRLKHIVW Gag(28-36) A*24:02 human epitope
                 qYkLKHIVW Gag(28-36) observed variant; susceptible form
                 rYrLKHlVW Gag(28-36) observed variant; susceptible form
                 QYKLKHIVW Gag(28-36) A*24:02 human epitope
                 kYrLKHIVW Gag(28-36) observed variant; susceptible form
                 rYrLKHlVW Gag(28-36) observed variant; susceptible form
                 KYKLKHIVW Gag(28-36) A*24:02 human epitope
                 RYRLKHLVW Gag(28-36) A*24:02 human epitope
                 kYRLKHiVW Gag(28-36) observed variant; susceptible form
                 qYkLKHiVW Gag(28-36) observed variant; susceptible form
                 HYMLKHLVW Gag(28-36) A*24:02 human epitope
                 KYKLKHIVW Gag(28-36) A*24:02 human epitope
                 KYKLKHIVW Gag(28-36) A*24:02 human epitope
                 KYKLKHIVW Gag(28-36) A*24:02 human epitope
                 KYrLKHIVW Gag(28-36) diminished response; escape documented in this paper; non-susceptible form
                 KYqLKHIVW Gag(28-36) diminished response; escape documented in this paper; non-susceptible form; susceptible form
                 KYKLKHIVW Gag(28-36) A*24:02 human epitope
                 KYKLKHIVW Gag(28-36) A*29 human epitope
                 KYKLKHIVW Gag(28-36) A*68:02 human epitope
                 KYKLKHIVW Gag(28-36) B*35:02, B*35:03, B*53:01 human epitope
                 KYKLKHIVW Gag(28-36) B*55 human epitope
                 KYKLKHIVW Gag(28-36) C*02 human epitope
                 KYRLKHLVW Gag(28-36) Cw4 human epitope
                 KYRLKHLVW Gag(28-36) Cw4 epitope
                 KYRLKHLVW Gag(28-36) Cw4 human epitope
                 KYKLKHIVW Gag(28-36) human epitope
                 KYKLKHIVW Gag(28-36) human epitope
                 KYRLKHLVW Gag(28-36) human epitope
                 KYkLKHLVW Gag(28-36) observed variant
                 KYKLKHIVW Gag(28-36) human epitope
                 KYRLKHLVW Gag(28-36) human epitope
                 KYRLKHIVW Gag(28-36) human epitope
                 KYKLKHIVW Gag(28-36) human epitope
                 HYMLNHIVW Gag(28-36) human epitope
                 HYMLKHLVW Gag(28-36) human epitope
                 KYKLKHIVW Gag(28-36) human epitope
                 HYMLKHLVWAS Gag(28-38) human epitope
                 KYKLKHIVWASRELER Gag(28-43) human epitope
                  YKLKHIVWA Gag(29-37) human epitope
                  YRLKHLVWASRELER Gag(29-43) human epitope
                  YRLKHLVWASRELER Gag(29-43) human epitope
                  YRLKHLVWASRELER Gag(29-43) human epitope
                  YRLKHLVWASRELER Gag(29-43) human epitope
                    LKHIVWASREL Gag(31-41) A*02:06 human epitope
                    mKHlVWASREL Gag(31-41) subtype-specific susceptible form
                    MKHLVWASREL Gag(31-41) A*02:06 human epitope
                    lKHiVWASREL Gag(31-41) subtype-specific susceptible form
                    MKHLVWASRELERFA Gag(31-45) human epitope
                    LKHIVWASRELERFAVNPGL Gag(31-50) human epitope
Questions or comments? Contact us at immuno@lanl.gov
 
Managed by Triad National Security, LLC for the U.S. Department of Energy’s National Nuclear Security Administration
Copyright © 2022 Triad National Security, LLC | Disclaimer/Privacy

Dept of Health & Human Services Los Alamos National Institutes of Health